1. Home
  2. HCM vs TPC Comparison

HCM vs TPC Comparison

Compare HCM & TPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • TPC
  • Stock Information
  • Founded
  • HCM 2000
  • TPC 1894
  • Country
  • HCM Hong Kong
  • TPC United States
  • Employees
  • HCM N/A
  • TPC N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • TPC General Bldg Contractors - Nonresidential Bldgs
  • Sector
  • HCM Health Care
  • TPC Consumer Discretionary
  • Exchange
  • HCM Nasdaq
  • TPC Nasdaq
  • Market Cap
  • HCM 2.6B
  • TPC 2.5B
  • IPO Year
  • HCM N/A
  • TPC N/A
  • Fundamental
  • Price
  • HCM $17.44
  • TPC $63.83
  • Analyst Decision
  • HCM
  • TPC Strong Buy
  • Analyst Count
  • HCM 0
  • TPC 3
  • Target Price
  • HCM N/A
  • TPC $60.67
  • AVG Volume (30 Days)
  • HCM 57.4K
  • TPC 534.4K
  • Earning Date
  • HCM 08-07-2025
  • TPC 11-05-2025
  • Dividend Yield
  • HCM N/A
  • TPC N/A
  • EPS Growth
  • HCM N/A
  • TPC N/A
  • EPS
  • HCM 0.53
  • TPC N/A
  • Revenue
  • HCM $602,197,000.00
  • TPC $4,770,779,000.00
  • Revenue This Year
  • HCM $2.73
  • TPC $23.30
  • Revenue Next Year
  • HCM $17.33
  • TPC $12.61
  • P/E Ratio
  • HCM $6.26
  • TPC N/A
  • Revenue Growth
  • HCM N/A
  • TPC 12.03
  • 52 Week Low
  • HCM $11.51
  • TPC $18.34
  • 52 Week High
  • HCM $21.50
  • TPC $65.60
  • Technical
  • Relative Strength Index (RSI)
  • HCM 60.43
  • TPC 70.30
  • Support Level
  • HCM $15.51
  • TPC $62.00
  • Resistance Level
  • HCM $18.30
  • TPC $65.60
  • Average True Range (ATR)
  • HCM 0.35
  • TPC 1.84
  • MACD
  • HCM 0.29
  • TPC 0.05
  • Stochastic Oscillator
  • HCM 76.18
  • TPC 80.29

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About TPC Tutor Perini Corporation

Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically, it derives key revenue from the United States.

Share on Social Networks: